Skip to main content
Commentary: JAK Inhibitors and Comorbidities in AD, December 2023
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Commentary: JAK Inhibitors and Comorbidities in AD, December 2023
User login
Username
Password
Reset your password
Concept
Lead
score
Dermatitis
1
1
Atopic Dermatitis
0
1
Monoclonal Antibody
0
0.85
Adverse Effects
0
0.75
Kidney Cancer
0
0.55
Dementia
0
0.55
Biologic Therapy
0
0.75
Herpes Viruses
0
0.55
Interleukin
0
0.85
Specialty
Lead
score
Dermatology
1
1
Allergy & Clinical Immunology
0
1
Family Medicine/Primary Care
0
1
Internal Medicine
0
1
Pediatrics
0
0.63
Edit Tags